HCP Inc. selloff overdone, says Argus Argus believes that HCP's 18% retreat since mid-May on fears of rising bond yields is overdone. The firm is encouraged by what it sees as HCP's accelerating same-property net operating income growth and improving occupancy trends. It is also upbeat about HCP's growth-through-acquisition strategy.and keeps a Buy rating on the stock.
